Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Chemical Biology|August 4, 2004
Emerging classes of protein-protein interaction inhibitors and new tools for their developmentLen Pagliaro, Jakob Felding, Karine Audouze, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Syntheses and antiproliferative evaluation of oxyphenisatin derivativesMuhammed K Uddin, Serge G Reignier, Tom Coulter, et al.Bioorganic & Medicinal Chemistry Letters|December 15, 2021
Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitorsThomas Flagstad, Mette T Pedersen, Tim H Jakobsen, et al.Angewandte Chemie (International Ed. in English)|September 30, 2015
C-H Oxidation of Ingenanes Enables Potent and Selective Protein Kinase C Isoform ActivationYehua Jin, Chien-Hung Yeh, Christian A Kuttruff, et al.Dermatology and Therapy|November 4, 2023
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative ReviewAndrew Blauvelt, Richard G Langley, Kenneth B Gordon, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2022
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tabletsRichard B Warren, Bruce Strober, Jonathan I Silverberg, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2022
Pharmacology of orismilast, a potent and selective PDE4 inhibitorJonathan I Silverberg, Lars E French, Richard B Warren, et al.Journal of Medicinal Chemistry|July 2, 2014
Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitisJakob Felding, Morten D Sørensen, Tina D Poulsen, et al.Journal of Medicinal Chemistry|January 5, 2002
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacologyTine B Stensbøl, Peter Uhlmann, Sandrine Morel, et al.ACS Central Science|January 4, 2018
Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis DrugsChristopher G Parker, Christian A Kuttruff, Andrea Galmozzi, et al.Pageof 3